Lasarrus develops devices for patients with chronic obstructive pulmonary disease.
Lasarrus has raised $499K in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Lasarrus's investors include National Science Foundation, TEDCO, National Institutes of Health, Particular Ventures.
Lasarrus is headquartered in Baltimore, United States.
Lasarrus develops devices for patients with chronic obstructive pulmonary disease.
Lasarrus is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lasarrus — Funding & Investors." VCBacked, September 20, 2024, https://www.vcbacked.co/company/lasarrus. Accessed July 19, 2026.
VCBacked. (2024). Lasarrus — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/lasarrus
{{cite web |title=Lasarrus — Funding & Investors |url=https://www.vcbacked.co/company/lasarrus |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated